Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,498 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02743494 | An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer(CheckMate 577) | completed | Phase 3 | 794 | Bristol-Myers SquibbINDUSTRY | 31 | Nov 18, 2025 | clinicaltrials |
| NCT06430177 | The Effect of Sujok Therapy on Patient Comfort, Pain Intensity, and Anxiety Level in Cancer Patients With Port Catheter Placement | completed | N/A | 60 | Firat UniversityOTHER | 1 | Nov 18, 2025 |
| clinicaltrials |
| NCT07232927 | Evaluation of Hemostatic Agents in Partial Nephrectomy(HEMOSTA-PN) | completed | N/A | 150 | Ankara UniversityOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07231913 | Emotional Awareness and Communication Training Effectiveness in Oncology Nurses | recruiting | N/A | 64 | Ankara Yildirim Beyazıt UniversityOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT07228533 | CesiKids Trial: Enhancing Psychological Resilience in Adolescents With Cancer | not yet recruiting | N/A | 36 | Eskisehir Osmangazi UniversityOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT03371017 | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer(IMpassion132) | completed | Phase 3 | 595 | Hoffmann-La RocheINDUSTRY | 28 | Nov 12, 2025 | clinicaltrials |
| NCT03539536 | Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer | active not recruiting | Phase 2 | 270 | AbbVieINDUSTRY | 26 | Nov 5, 2025 | clinicaltrials |
| NCT03229200 | Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. | active not recruiting | Phase 4 | 297 | Pharmacyclics Switzerland GmbHINDUSTRY | 17 | Oct 30, 2025 | clinicaltrials |
| NCT03036488 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) | completed | Phase 3 | 1,174 | Merck Sharp & Dohme LLCINDUSTRY | 21 | Oct 29, 2025 | clinicaltrials |
| NCT04875195 | A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68) | completed | Phase 2 | 66 | Merck Sharp & Dohme LLCINDUSTRY | 11 | Oct 29, 2025 | clinicaltrials |
| NCT04194944 | A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer(LIBRETTO-431) | active not recruiting | Phase 3 | 261 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 21, 2025 | clinicaltrials |
| NCT04551066 | To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) | terminated | Phase 3 | 252 | Incyte CorporationINDUSTRY | 17 | Oct 21, 2025 | clinicaltrials |
| NCT02367040 | Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)(CHRONOS-3) | completed | Phase 3 | 458 | BayerINDUSTRY | 37 | Oct 14, 2025 | clinicaltrials |
| NCT02767804 | eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients | active not recruiting | Phase 3 | 290 | Xcovery Holdings, Inc.INDUSTRY | 20 | Oct 14, 2025 | clinicaltrials |
| NCT04931654 | A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer | active not recruiting | Phase 1 / Phase 2 | 136 | AstraZenecaINDUSTRY | 10 | Oct 9, 2025 | clinicaltrials |
| NCT04189445 | Futibatinib in Patients With Specific FGFR Aberrations | terminated | Phase 2 | 115 | Taiho Oncology, Inc.INDUSTRY | 15 | Oct 8, 2025 | clinicaltrials |
| NCT05564052 | A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma(VEGA) | completed | Phase 2 | 36 | Janssen Research & Development, LLCINDUSTRY | 13 | Oct 7, 2025 | clinicaltrials |
| NCT04447755 | A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)(E7080-G000-231) | completed | Phase 2 | 127 | Merck Sharp & Dohme LLCINDUSTRY | 20 | Oct 3, 2025 | clinicaltrials |
| NCT04551053 | To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) | terminated | Phase 3 | 177 | Incyte CorporationINDUSTRY | 19 | Oct 2, 2025 | clinicaltrials |
| NCT06676228 | Fear of Cancer Recurrence Therapy (FORT): Turkish Cultural Adaptation and Implementation Project | completed | N/A | 100 | Maltepe UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT07203989 | The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor | not yet recruiting | N/A | 124 | Bitlis Eren UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04659603 | Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors(CARMEN-BT01) | terminated | Phase 2 | 50 | SanofiINDUSTRY | 10 | Oct 1, 2025 | clinicaltrials |
| NCT06389357 | Retun-to-school Adaptation Program for Children With Cancer(web-based) | completed | N/A | 20 | Gazi UniversityOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06209463 | Posture, Hand Functions and Sensory Processing Skills on Nutrition | completed | — | 80 | Bezmialem Vakif UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT05191212 | Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer | completed | N/A | 80 | Bakirkoy Dr. Sadi Konuk Research and Training HospitalOTHER_GOV | 1 | Sep 24, 2025 | clinicaltrials |
| NCT05933577 | A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) | active not recruiting | Phase 3 | 1,089 | Merck Sharp & Dohme LLCINDUSTRY | 26 | Sep 24, 2025 | clinicaltrials |
| NCT06019325 | Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy | completed | N/A | 254 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07189247 | Evaluation of Fibromyalgia Frequency and Pain Parameters in Women With Polycystic Ovary Syndrome | not yet recruiting | — | 140 | Ufuk UniversityOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT05240209 | Skin Cancer, Self Skin Examination and Sun Protection Behaviors Training(RCT) | completed | N/A | 300 | Saglik Bilimleri UniversitesiOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06424938 | Postoperative Analgesia in Major Gynecological Cancer Surgeries | completed | N/A | 71 | Duygu AkyolOTHER_GOV | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07185711 | RFA and Bite Force in COD Teeth | completed | N/A | 17 | Eskisehir Osmangazi UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07186257 | Impact of Uterine Leiomyoma Location on Uterine Artery Doppler Velocimetry(ULLADS) | completed | — | 185 | Bakirkoy Dr. Sadi Konuk Research and Training HospitalOTHER_GOV | 1 | Sep 22, 2025 | clinicaltrials |
| NCT01909934 | Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma | completed | Phase 4 | 50 | TakedaINDUSTRY | 10 | Sep 19, 2025 | clinicaltrials |
| NCT05377021 | Lifestyle Change in Women With Polycystic Ovary Syndrome | completed | N/A | 27 | Dokuz Eylul UniversityOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT05382286 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer(ASCENT-04) | active not recruiting | Phase 3 | 443 | Gilead SciencesINDUSTRY | 28 | Sep 18, 2025 | clinicaltrials |
| NCT06970821 | Association of Vitamin D Status With Metabolic Markers in Adolescents With Polycystic Ovary Syndrome | completed | — | 106 | Bagcilar Training and Research HospitalOTHER_GOV | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07170670 | Cognitive-Behavioral Care for Port Needle Insertion | completed | N/A | 54 | Birgul ErdoganOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07177560 | Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)(DICLO-HFS) | completed | — | 151 | Gazi UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06702436 | Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)"(CAN-NSTEMI) | completed | — | 12,500 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT07175558 | Effects of Reiki Applied to Patients Undergoing Colorectal Cancer Surgery on Postoperative Pain, Anxiety, Physiological Parameters and Recovery | completed | N/A | 64 | Istanbul University - CerrahpasaOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT06856590 | ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction(ZINCLO-HAND) | completed | N/A | 150 | Gazi UniversityOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07168616 | Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance(I-SELECT) | recruiting | — | 201 | Istanbul University - CerrahpasaOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06012786 | Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema | completed | — | 110 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06184074 | Effect of Aromatase Inhibitors on Ultrasonographic Measurements and Static and Dynamic Balance Scores in Breast Cancer | completed | — | 76 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06905925 | The Effect of the Training Program Given to Permanent Colostomy Patients on Self-efficacy | recruiting | N/A | 70 | Cukurova UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07159958 | Simulation Supported Vulva Cancer and Self-Examination on Knowledge, Skills and Attitude | completed | N/A | 94 | Trakya UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07160062 | Mandala Painting on Perioperative Psychological Well-Being,Emotional Self-Efficacy,Anxiety | completed | N/A | 84 | Trakya UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07171151 | Detection of Disease Marker Factors in Cyst Fluid | recruiting | — | 25 | Harran UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04478266 | Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer(AMEERA-5) | terminated | Phase 3 | 1,068 | SanofiINDUSTRY | 30 | Sep 11, 2025 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials